158 related articles for article (PubMed ID: 2909283)
1. Inhibition of murine hepatic tumor growth by liposomes containing a lipophilic muramyl dipeptide.
Brodt P; Blore J; Phillips NC; Munzer JS; Rioux JD
Cancer Immunol Immunother; 1989; 28(1):54-8. PubMed ID: 2909283
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of experimental liver tumor growth in mice by liposomes containing a lipophilic muramyl dipeptide derivative.
Phillips NC; Tsao MS
Cancer Res; 1989 Feb; 49(4):936-9. PubMed ID: 2912563
[TBL] [Abstract][Full Text] [Related]
3. Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide.
Phillips NC; Rioux J; Tsao MS
Hepatology; 1988; 8(5):1046-50. PubMed ID: 2971013
[TBL] [Abstract][Full Text] [Related]
4. Liposomal muramyl dipeptide therapy of experimental M5076 liver metastases in mice.
Phillips NC; Tsao MS
Cancer Immunol Immunother; 1991; 33(2):85-90. PubMed ID: 2036662
[TBL] [Abstract][Full Text] [Related]
5. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
Phillips NC; Chedid L; Bernard JM; Level M; Lefrancier P
J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784
[TBL] [Abstract][Full Text] [Related]
6. Activation of alveolar macrophage tumoricidal activity and eradication of experimental metastases by freeze-dried liposomes containing a new lipophilic muramyl dipeptide derivative.
Phillips NC; Moras ML; Chedid L; Lefrancier P; Bernard JM
Cancer Res; 1985 Jan; 45(1):128-34. PubMed ID: 3838084
[TBL] [Abstract][Full Text] [Related]
7. Tumor cell binding and induction of endothelial cell tumoricidal activity in vitro by muramyl dipeptide is enhanced by liposomal encapsulation.
Phillips NC; Stewart-Phillips J; Wang P
J Immunother Emphasis Tumor Immunol; 1994 Apr; 15(3):185-93. PubMed ID: 8032541
[TBL] [Abstract][Full Text] [Related]
8. Induction of colony-stimulating activity in mice by injection of liposomes containing lipophilic muramyl peptide derivatives.
Galelli A; Charlot B; Phillips NC; Chedid L
Cancer Res; 1989 Feb; 49(4):810-5. PubMed ID: 2783556
[TBL] [Abstract][Full Text] [Related]
9. Therapy of murine liver metastases by administration of MDP encapsulated in liposomes.
Daemen T; Dontje BH; Veninga A; Scherphof GL; Oosterhuis WL
Sel Cancer Ther; 1990; 6(2):63-71. PubMed ID: 2367753
[TBL] [Abstract][Full Text] [Related]
10. Activation of macrophage cytostatic and cytotoxic activity in vitro by liposomes containing a new lipophilic muramyl peptide derivative, MDP-L-alanyl-cholesterol (MTP-CHOL).
Phillips NC; Moras ML; Chedid L; Petit JF; Tenu JP; Lederer E; Bernard JM; Lefrancier P
J Biol Response Mod; 1985 Oct; 4(5):464-74. PubMed ID: 3935756
[TBL] [Abstract][Full Text] [Related]
11. Eradication of hepatic metastases of carcinoma H-59 by combination chemoimmunotherapy with liposomal muramyl tripeptide, 5-fluorouracil, and leucovorin.
Asao T; Shibata HR; Batist G; Brodt P
Cancer Res; 1992 Nov; 52(22):6254-7. PubMed ID: 1423270
[TBL] [Abstract][Full Text] [Related]
12. Chemoimmunotherapy of murine liver metastases with 5-fluorouracil in combination with liposome-encapsulated muramyl dipeptide.
Daemen T; Dontje BH; Regts J; Scherphof GL
J Immunother Emphasis Tumor Immunol; 1993 Jan; 13(1):31-5. PubMed ID: 8435429
[TBL] [Abstract][Full Text] [Related]
13. MDP-Lys(L18), a lipophilic derivative of muramyl dipeptide, inhibits the metastasis of haematogenous and non-haematogenous tumours in mice.
Yoo YC; Saiki I; Sato K; Azuma I
Vaccine; 1994 Feb; 12(2):175-60. PubMed ID: 8147100
[TBL] [Abstract][Full Text] [Related]
14. Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in liposomes on tumor cell killing by human monocytes.
Sone S; Mutsuura S; Ogawara M; Tsubura E
J Immunol; 1984 Apr; 132(4):2105-10. PubMed ID: 6699409
[TBL] [Abstract][Full Text] [Related]
15. Functional characteristics of the rat liver macrophage population after a single intravenous injection of liposome-encapsulated muramyl peptides.
Hoedemakers RM; Vossebeld PJ; Daemen T; Scherphof GL
J Immunother Emphasis Tumor Immunol; 1993 May; 13(4):252-60. PubMed ID: 8334109
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of Kupffer cell tumoricidal activity by liposomal muramyl dipeptides.
Phillips NC
Res Immunol; 1992 Feb; 143(2):205-10. PubMed ID: 1574649
[No Abstract] [Full Text] [Related]
17. Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases.
Fidler IJ; Schroit AJ
J Immunol; 1984 Jul; 133(1):515-8. PubMed ID: 6373933
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of tumor growth in mice treated with synthetic muramyl dipeptide.
BubenÃk J; Jezek J; Zaoral M; Hofmann J; Gruntenko YV; Osipov JG; Zolotareva AG; Vakhrusheva TE; Budker VG
Cancer Immunol Immunother; 1984; 18(2):123-5. PubMed ID: 6568871
[TBL] [Abstract][Full Text] [Related]
19. Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide.
Fidler IJ; Sone S; Fogler WE; Barnes ZL
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1680-4. PubMed ID: 6940181
[TBL] [Abstract][Full Text] [Related]
20. Production of tumor necrosis factor in nude mice by muramyl peptides associated with bacterial vaccines.
Noso Y; Parant M; Parant F; Chedid L
Cancer Res; 1988 Oct; 48(20):5766-9. PubMed ID: 3167834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
